Biotech

All Articles

Lilly articles more good information on its own weekly blood insulin prospect

.On the heels of an FDA being rejected for its main rival Novo Nordisk, Eli Lilly is actually pushin...

IN 8bio standstills period 2 trial, lays off one-half of staff

.Just a handful of months after application the first individual in a stage 2 test for recently diag...

Lilly, Haya ink $1B biobuck excessive weight pact to look black genome

.Eli Lilly's hunt for obesity intendeds has led it to the dark genome. The Big Pharma has put togeth...

ArsenalBio elevates $325M, rotates away from former lead possession

.Arsenal Biosciences is actually going on up. The tissue treatment firm has added $325 thousand in a...

Lilly- supported weight-loss biotech reports IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually f...

Aelis' marijuana make use of medicine fails phase 2b, steering Indivior to reassess $100M choice

.Aelis Farma's chances of safeguarding a simple, positive decision on a $one hundred million possibi...

ProKidney halts period 3 trial certainly not required for cell therapy approval

.ProKidney has quit among a set of stage 3 trials for its own cell treatment for renal health condit...

Vaxcyte rises on 'magnificent' 31-valent PCV gain against Pfizer

.Vaxcyte introduced what experts called "spectacular" phase 1/2 records for its own 31-valent pneumo...

Recursion's mind condition test presents insufficient evidence of effectiveness

.Recursion has discovered via an early test of its tech-enabled approach to drug revelation, reporti...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Phone it a scenario of good chemistry: Acepodia, a biotech based on Nobel Prize-winning scientific ...